Ugandan drug maker starts supplying ARVs to South Africa

Friday May 1 2020

Cipla Quality Chemicals CEO Nevin Bradford

Cipla Quality Chemicals CEO Nevin Bradford (left) flags off Cipla's first shipment of ARVs to South Africa in March. PHOTO | CIPLA 

JULIUS BARIGABA
By JULIUS BARIGABA
More by this Author

Ugandan pharmaceutical company Cipla has started supplying antiretroviral drugs to South Africa.

Cipla Quality Chemicals CEO, Nevin Bradford, says the drug maker is supplying ARVs to the country through an affiliate group, Cipla South Africa.

He, however, declined to reveal the value of the deal saying its "rather confidential".

"Our first supply was in March…the supply was 300,000 packs of triple combination drug TEE (Tenofovir/Emtricitabine/Efavirenz/)," Bradford told The EastAfrican on Friday

He said that under the deal, Cipla will supply drugs until March next year.

In addition, Cipla will also supply a first line ARV drug TLD through its South Africa-based sister company. 

Advertisement

The firm has supplied malaria drugs and ARVs to countries including Kenya, Tanzania, Rwanda, Ghana, Sierra Leone, Liberia, Namibia, Zambia, Zimbabwe, Mozambique, Comoros and Cameroon.

Advertisement